Watch MYOK today - positive clinical news - also they have file a shelf registration to sell stock

President, Capitol Isle Partners • Mar 9, 2018 at 8:48 AM EST

MYOK has a history of doing stock offerings when the price runs up on good news. To get extra flexibility, they file a shelf offering so they can issue the stock at a "to be determined price." This allows them to take advantage of the price run up without killing the momentum Stay tuned..

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

GlobeNewswire•March 8, 2018

Met Primary Endpoint and Key Secondary Endpoints with Statistical Significance

Study Results Inform Phase 3 EXPLORER-HCM Dosing;
First Patient Planned for Q2 2018

Conference Call Today at 4:30 p.m. ET (1:30 p.m. PT); Data Presentation at American College of Cardiology on Sunday, March 11, 2018

https://finance.yahoo.com/news/myokardia-announces-positive-results-low-210200236.html

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Back to TalkMarkets

MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

More from this Author

BioTelemetry: New Disruptive Technology With Major Growth Ahead

A 45%+ Crash Could Be Coming For The Market - Here's Why